Targeting NLRP3 Inflammasome for Neurodegenerative Disorders

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2023 Sep 5

PMID 37670126

Authors

Jing Yao

Zhe Wang

Weihong Song

Yun Zhang

Affiliations

Soon will be listed here.

Abstract

Neuroinflammation is a key pathological feature in neurological diseases, including Alzheimer's disease (AD). The nucleotide-binding domain leucine-rich repeat-containing proteins (NLRs) belong to the pattern recognition receptors (PRRs) family that sense stress signals, which play an important role in inflammation. As a member of NLRs, the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) is predominantly expressed in microglia, the principal innate immune cells in the central nervous system (CNS). Microglia release proinflammatory cytokines to cause pyroptosis through activating NLRP3 inflammasome. The active NLRP3 inflammasome is involved in a variety of neurodegenerative diseases (NDs). Recent studies also indicate the key role of neuronal NLRP3 in the pathogenesis of neurological disorders. In this article, we reviewed the mechanisms of NLRP3 expression and activation and discussed the role of active NLRP3 inflammasome in the pathogenesis of NDs, particularly focusing on AD. The studies suggest that targeting NLRP3 inflammasome could be a novel approach for the disease modification.

Citing Articles

NLRP3 inflammasome in neuroinflammation and central nervous system diseases.

Xu W, Huang Y, Zhou R Cell Mol Immunol. 2025; .

PMID: 40075143 DOI: 10.1038/s41423-025-01275-w.

Serotype and distribution of adhesion genes in Streptococcus mutans isolated from people with Parkinson's disease.

Donnet L, Claisse O, Samot J Odontology. 2025; .

PMID: 40048130 DOI: 10.1007/s10266-025-01078-5.

Inactivation of NLRP3 inflammasome by dephosphorylation at Serine 658 alleviates glial inflammation in the mouse model of Parkinson's disease.

Zhu R, Han R, Chen Y, Huang L, Liu T, Jiang J Mol Neurodegener. 2025; 20(1):27.

PMID: 40038816 PMC: 11881452. DOI: 10.1186/s13024-025-00818-z.

Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer's Disease and Regulation by Natural Plant Products.

Zu R, Lu H, Liu W, Shao S, Zheng J, Ying X Mol Neurobiol. 2025; .

PMID: 39875780 DOI: 10.1007/s12035-025-04715-w.

Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation.

Chen J, Jia S, Xue X, Guo C, Dong K Front Microbiol. 2025; 15():1476908.

PMID: 39834360 PMC: 11743191. DOI: 10.3389/fmicb.2024.1476908.

References

Hoffman H, Wright F, Broide D, Wanderer A, Kolodner R . Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet. 2000; 66(5):1693-8. PMC: 1378006. DOI: 10.1086/302874. View

Yanagisawa S, Katoh H, Imai T, Nomura S, Watanabe M . The relationship between inflammasomes and the endoplasmic reticulum stress response in the injured spinal cord. Neurosci Lett. 2019; 705:54-59. DOI: 10.1016/j.neulet.2019.04.033. View

Alfonso-Loeches S, Urena-Peralta J, Morillo-Bargues M, Oliver-De La Cruz J, Guerri C . Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells. Front Cell Neurosci. 2014; 8:216. PMC: 4118026. DOI: 10.3389/fncel.2014.00216. View

Martinon F, Burns K, Tschopp J . The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002; 10(2):417-26. DOI: 10.1016/s1097-2765(02)00599-3. View

Mayor A, Martinon F, De Smedt T, Petrilli V, Tschopp J . A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat Immunol. 2007; 8(5):497-503. DOI: 10.1038/ni1459. View

de Alba E . Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). J Biol Chem. 2009; 284(47):32932-41. PMC: 2781708. DOI: 10.1074/jbc.M109.024273. View

Lu A, Magupalli V, Ruan J, Yin Q, Atianand M, Vos M . Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014; 156(6):1193-1206. PMC: 4000066. DOI: 10.1016/j.cell.2014.02.008. View

Kostura M, Tocci M, Limjuco G, Chin J, Cameron P, Hillman A . Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A. 1989; 86(14):5227-31. PMC: 297594. DOI: 10.1073/pnas.86.14.5227. View

He W, Wan H, Hu L, Chen P, Wang X, Huang Z . Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 2015; 25(12):1285-98. PMC: 4670995. DOI: 10.1038/cr.2015.139. View

10.

Sharif H, Wang L, Wang W, Magupalli V, Andreeva L, Qiao Q . Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019; 570(7761):338-343. PMC: 6774351. DOI: 10.1038/s41586-019-1295-z. View

11.

Li X, Thome S, Ma X, Amrute-Nayak M, Finigan A, Kitt L . MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism. Nat Commun. 2017; 8:15986. PMC: 5493753. DOI: 10.1038/ncomms15986. View

12.

Lang T, Lee J, Elgass K, Pinar A, Tate M, Aitken E . Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation. Nat Commun. 2018; 9(1):2223. PMC: 5993818. DOI: 10.1038/s41467-018-04581-2. View

13.

Mohamed I, Hafez S, Fairaq A, Ergul A, Imig J, El-Remessy A . Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia. 2013; 57(2):413-23. PMC: 3947289. DOI: 10.1007/s00125-013-3101-z. View

14.

Park S, Juliana C, Hong S, Datta P, Hwang I, Fernandes-Alnemri T . The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol. 2013; 191(8):4358-66. PMC: 3848201. DOI: 10.4049/jimmunol.1301170. View

15.

Samir P, Kesavardhana S, Patmore D, Gingras S, Malireddi R, Karki R . DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome. Nature. 2019; 573(7775):590-594. PMC: 6980284. DOI: 10.1038/s41586-019-1551-2. View

16.

Heneka M, Kummer M, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A . NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 2012; 493(7434):674-8. PMC: 3812809. DOI: 10.1038/nature11729. View

17.

Gordon R, Albornoz E, Christie D, Langley M, Kumar V, Mantovani S . Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018; 10(465). PMC: 6483075. DOI: 10.1126/scitranslmed.aah4066. View

18.

Mulazzani E, Wagner D, Havla J, Schluter M, Meinl I, Gerdes L . Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants. J Neuroinflammation. 2020; 17(1):196. PMC: 7306142. DOI: 10.1186/s12974-020-01867-5. View

19.

Park K, Shen B, Parmeggiani F, Huang P, Stoddard B, Baker D . Control of repeat-protein curvature by computational protein design. Nat Struct Mol Biol. 2015; 22(2):167-74. PMC: 4318719. DOI: 10.1038/nsmb.2938. View

20.

Duan Y, Wang J, Cai J, Kelley N, He Y . The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages. J Biol Chem. 2022; 298(12):102717. PMC: 9763864. DOI: 10.1016/j.jbc.2022.102717. View